Evaluating the Educational Value of Artificial Intelligence in Pharmacotherapy Education
Pharmacology Research & Perspectives · 2026-06 · 14 (3)
DOI: 10.1002/prp2.70266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 20.05.2026. Verfasst von Mariëlle G Hartjes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Internal Medicine, Unit Pharmacotherapy, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Artificial Intelligence, Education, Medical. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Final‐year medical students frequently make prescribing errors, partly because they have had insufficient training in therapeutic reasoning. Students need to understand the underlying rationale behind a drug choice in order to subsequently apply that knowledge critically and independently. Artificial intelligence (AI) models are becoming increasingly popular among students for therapeutic case solving, but the educational value of these models remains unclear. Therefore, the reasoning process of ChatGPT 3.5 (a general AI model) and EvidenceHunt basic (a specialized medical AI model) was compared with that of a medical specialist/clinical pharmacologist, according to the WHO 6‐step. Although both AI models proposed reasonable treatment options, notable differences from those of the medical specialist were observed. The AI models tended to focus primarily on pharmacological recommendations for the main clinical problem, giving less consideration to broader contextual factors, such as the severity of illness. Some inaccuracies and illogical therapeutic alternatives were also identified. While AI models, such as ChatGPT and EvidenceHunt, show potential to improve education in therapeutic reasoning by suggesting plausible treatment options, their reasoning remains limited. They often justify rather than critically evaluate treatment choices, which restricts their depth, especially when it comes to considering alternative therapies and complex patient factors. For AI to be of real educational benefit, students will need to develop reflective skills so that they can critically appraise AI recommendations instead of passively accepting them. Teachers can encourage this by asking students to explain their treatment choices, thereby helping them to strengthen these skills.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Internal Medicine, Unit Pharmacotherapy, Amsterdam, the Netherlands.
- Research and Expertise Centre in Pharmacotherapy Education (RECIPE), Amsterdam, HV, the Netherlands.
- Interprofessional Collaboration and Medication Safety, Faculty of Health, Sports and Social Work, InHolland University of Applied Sciences, Amsterdam, HV, the Netherlands.
- University Medical Center Utrecht, Department of Surgery, Utrecht, CX, the Netherlands.
ORCID-Profile: Michiel A van Agtmael
Zitieren
APA
Hartjes, M. G., Bakkum, M. J., Richir, M. C., van Agtmael, M. A., & Tichelaar, J. (2026). Evaluating the Educational Value of Artificial Intelligence in Pharmacotherapy Education. Pharmacology Research & Perspectives, 14(3). https://doi.org/10.1002/prp2.70266
Vancouver
Hartjes MG, Bakkum MJ, Richir MC, van Agtmael MA, Tichelaar J. Evaluating the Educational Value of Artificial Intelligence in Pharmacotherapy Education. Pharmacology Research & Perspectives. 2026;14(3). doi:10.1002/prp2.70266
BibTeX
@article{Hartjes2026,
author = {Hartjes, Mariëlle G and Bakkum, Michiel J and Richir, Milan C and van Agtmael, Michiel A and Tichelaar, Jelle},
title = {Evaluating the Educational Value of Artificial Intelligence in Pharmacotherapy Education},
journal = {Pharmacology Research & Perspectives},
year = {2026},
volume = {14},
number = {3},
doi = {10.1002/prp2.70266}
}
EUVIMED